Thought Leadership - Spherix Global Insights

Invest in intelligence that delivers

Spherix Thought Leadership

From conference presentations to white papers and other publicly shared research, access a comprehensive collection to stay informed and drive impactful decisions.

Gastroenterology

Rezdiffra and Wegovy are Just the Beginning: Vast Unmet Needs and Opportunities Remain in the Fight Against MASH

Hematology

Gene Therapy in Hematology: What Explains the Uptake Gap?

Nephrology

A New Era in Kidney Disease Treatment? Rapid Adoption of SGLT2is and GLP-1s Signals Shifting Paradigms

Nephrology

Same Disease, Different Stories: Contrasting Patient and Physician Perspectives in IgA Nephropathy

Nephrology

A New Era for FSGS Treatment

Rheumatology

Navigating the Evolving SLE/Lupus Nephritis Landscape: Keys to Successful Product Launches

Hematology

Advancing Hemophilia Care: Insights from U.S. Hematologists on Novel Therapies and Clinical Practice Trends

Hematology

Advancing Hemophilia Care: Insights from U.S. Hematologists on Novel Therapies and Clinical Practice Trends

Hematology

New treatment dynamics in PNH – a chart review of 211 US PNH patients and how physicians are adapting to new treatment options

Cross Specialty

Discussion on the Inflation Reduction Act During the Healthcare Businesswomen's Association Virtual Event

Dermatology

Earlier Diagnosis and Treatment: The Key to Better Outcomes in Hidradenitis Suppurativa

Dermatology

Understand the remaining unmet need in plaque psoriasis and to uncover early perceptions of the oral small molecules in development for plaque psoriasis.

Nephrology

A Complement and B-Cell Modifying Pipeline to Address Unmet Needs in IgA Nephropathy (IgAN)

Rheumatology

Chart Audit of Over 1,000 SLE Patients Reveals Biologic Treatment Choice Driven by Disease Manifestations

Nephrology

A Comparative View of Early Career and Established Nephrologist Perspectives

Dermatology

Uptake of Secukinumab in Hidradenitis Suppurativa

CNS

A KOL Perspective: Exclusive Interview with Dr. Naismith

Rheumatology

Not Yet on Track: Retrospective Chart Analysis Reveals Physician’s Treatment Approaches in SLE Fall Short of New EULAR Guidance

Nephrology

Evolution of Treatment Paradigms in Diabetic Kidney Disease

CNS

Characterization of Early Adopters of SC FcRn Blockers for gMG

Nephrology

The Untapped Potential of the ADPKD Treatment Landscape

Rheumatology

Amplifying the Lupus Patient Voice: Insights into the Diagnostic Journey and Informational Needs

Nephrology

The Meteoric Rise of SGLT2 Inhibitors in Glomerular Diseases

Dermatology

Acceptable Clinical Trial Differences vs Placebo in Plaque Psoriasis

Nephrology

A Comparative View of IgA Nephropathy Care Across Four Global Regions

Nephrology

Genetic Testing in Patients with Focal Segmental Glomerulosclerosis

Rheumatology

Specialists' Comfort with Cutaneous Lupus Erythematosus Reveals Potential Gaps and a Need for Co- Management Strategies

CNS

The Uptake of Relyvrio™ (sodium phenylbutyrate and taurursodiol) in ALS among General Neurologists Compared to Neuromuscular Specialists and to ALS Center Affiliated Neurologists

Nephrology

Uncovering the Potential of HIF-PH Inhibitors to Treat Renal Anemia

Nephrology

Shifts in SGLT2 Inhibitor Initiation in CKD Non-Dialysis Patients

Media

January 20, 2026

Spherix Global Insights Highlights Evolving PD-1 Landscape as Subcutaneous Use Grows and Biosimilars Approach across Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

January 14, 2026

New Spherix Patient Research Shows Nearly Half of Atopic Dermatitis Patients Report Major Quality-of-Life Impact Despite Expanding Treatment Options

January 8, 2026

AZ looks to grow reach in lupus with phase 3 win for self-administered Saphnelo

January 6, 2026

Talk to an expert

Andy Stankus
Franchise Head, Dermatology

Jim Hickey
Franchise Head, Gastroenterology

Andy Stankus
Franchise Head, Rheumatology

Kari McCarthy
Franchise Head, Nephrology

Bob Shewbrooks
Franchise Head, CNS

Bob Shewbrooks
Franchise Head, Ophthalmology

Sarah Hendry
Franchise Head, Hematology